Literature DB >> 16328965

Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Haşim Boyaci1, Hale Maral, Gupse Turan, Ilknur Başyiğit, Meltem O Dillioğlugil, Füsun Yildiz, Melih Tugay, Ayşe Pala, Cengiz Erçin.   

Abstract

This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague-Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin + erdosteine (BLM + ERD), and saline alone (control). The BLM and BLM + ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM + ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM + ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 +/- 0.15, 0.11 +/- 0.02, and 0.087+/- 0.03 nmol/mg protein in BLM, BLM + ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 +/- 0.06, 0.60 +/- 0.09, and 0.56+/- 0.1 micromol/mg protein in BLM, BLM + ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 +/- 12.4, 253.2+/- 25.2, and 287.9+/- 34.4 nmol/mg protein) (SOD levels were 1.42+/- 0.12, 1.75+/- 0.17, and 1.89+/- 0.09 U/mg protein) in BLM, BLM + ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16328965     DOI: 10.1007/s11010-006-0640-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis.

Authors:  J C Weissler
Journal:  Am J Med Sci       Date:  1989-02       Impact factor: 2.378

2.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

3.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

5.  Decreasing the oxidant stress from paraquat in isolated perfused rat lung using captopril and niacin.

Authors:  Mahmoud Ghazi-Khansari; Ghodratolla Nasiri; Marzyieh Honarjoo
Journal:  Arch Toxicol       Date:  2005-04-23       Impact factor: 5.153

6.  Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Zeki Yildirim; Yusuf Turkoz; Mahir Kotuk; Ferah Armutcu; Ahmet Gurel; Mustafa Iraz; Suleyman Ozen; Ismet Aydogdu; Omer Akyol
Journal:  Nitric Oxide       Date:  2004-09       Impact factor: 4.427

7.  Effects on the reactive oxygen species of erdosteine and its metabolite in vitro.

Authors:  Hisashi Hosoe; Toshihiko Kaise; Kenji Ohmori
Journal:  Arzneimittelforschung       Date:  2002

8.  Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.

Authors:  E Ege; A Ilhan; A Gurel; O Akyol; S Ozen
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-10       Impact factor: 7.069

9.  Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats.

Authors:  W A Dik; R J McAnulty; M A Versnel; B A E Naber; L J I Zimmermann; G J Laurent; S E Mutsaers
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

10.  Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.

Authors:  Ersin Fadillioğlu; Hasan Erdoğan; Sadik Söğüt; Irfan Kuku
Journal:  J Appl Toxicol       Date:  2003 Jan-Feb       Impact factor: 3.446

View more
  12 in total

1.  Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.

Authors:  Göksel Sener; A Ozer Sehirli; Hale Z Toklu; Meral Yuksel; Feriha Ercan; Nursal Gedik
Journal:  Pediatr Surg Int       Date:  2007-01-10       Impact factor: 1.827

2.  Nano-Se attenuates cyclophosphamide-induced pulmonary injury through modulation of oxidative stress and DNA damage in Swiss albino mice.

Authors:  Arin Bhattacharjee; Abhishek Basu; Jaydip Biswas; Sudin Bhattacharya
Journal:  Mol Cell Biochem       Date:  2015-04-29       Impact factor: 3.396

3.  Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.

Authors:  Sally A Abuelezz; Nevien Hendawy; Wesam M Osman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-07       Impact factor: 3.000

4.  Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.

Authors:  Göksel Sener; Halil Aksoy; Ozer Sehirli; Meral Yüksel; Cenk Aral; Nursal Gedik; Sule Cetinel; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 5.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

6.  Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis.

Authors:  Shin-Hwa Lee; An-Soo Jang; Young-Eun Kim; Ji-Yeon Cha; Tae-Hoon Kim; Seok Jung; Seong-Kyu Park; You-Kyoung Lee; Jong-Ho Won; Yong-Hoon Kim; Choon-Sik Park
Journal:  Respir Res       Date:  2010-02-08

7.  The protective effect of erdosteine on vancomycin-induced pancreatic damage in rats.

Authors:  Ahmet Koyu; Osman Gokalp; Faruk Oktem; Soner Donmez; Mustafa Dogan; Nermin Karahan; Nurhan Gumral; Nigar Yilmaz; Ahmet Kocak
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

Review 8.  Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.

Authors:  R-M Liu; K A Gaston Pravia
Journal:  Free Radic Biol Med       Date:  2009-10-02       Impact factor: 7.376

9.  Adaptability to hypobaric hypoxia is facilitated through mitochondrial bioenergetics: an in vivo study.

Authors:  Loganathan Chitra; Rathanam Boopathy
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 10.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.